Member Login
  1. Stocks
    2. /
  2. AstraZeneca PLC (LSE: AZN)
    3. /

LSE:AZN (AstraZeneca PLC)

About AZN

AstraZeneca is a biopharmaceutical business that focuses on the discovery, development and commercialisation of prescription medicines, primarily for the treatment of diseases in three main therapy areas - Respiratory, Inflammation and Autoimmunity (RIA), Cardiovascular and Metabolic Disease (CVMD) and Oncology – as well as in Infection and Neuroscience.
Financial Market Data copyright © 2025 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

AstraZeneca PLC (LSE: AZN) Latest News

Affectionate Asian senior mother and daughter using smartphone together at home, smiling joyfully
Investing Articles

Tempted by the AstraZeneca share price? Here’s why it could explode in 2023

| Charlie Carman

The AstraZeneca share price has more than doubled over five years. Our writer outlines why the FTSE 100 healthcare stock…

Read more »

Inflation in newspapers
Investing Articles

2 inflation-resistant stocks I’d like to buy right now

| Ben McPoland

These two firms are on my 'stocks to buy' list for when I have more cash to invest. Both seem…

Read more »

Investing Articles

3 ‘no-brainer’ FTSE 100 shares I’d buy for 2023

| Harshil Patel

FTSE 100 top picks! Our writer considers diversification, resilience and business quality to find the best shares for his ISA…

Read more »

Middle-aged white man pulling an aggrieved face while looking at a screen
Investing Articles

Revealed! The most sold FTSE 100 stocks by Hargreaves Lansdown investors

| Royston Wild

Demand for these FTSE 100 stocks sank among Hargreaves Lansdown clients this year. But could they rebound in 2023?

Read more »

Investing Articles

Are AstraZeneca shares a growth buy for 2023?

| Roland Head

AstraZeneca's surging share price has made it the most valuable business in the FTSE 100. Roland Head analyses what's next…

Read more »

Investing Articles

Top 2 FTSE 100 shares to buy for 2023

| Harshil Patel

2023 FTSE 100 top picks are here! Our writer takes an early look at the best shares to buy for…

Read more »

Young female business analyst looking at a graph chart while working from home
Investing Articles

If I’d invested £500 in AstraZeneca shares 2 years ago, here’s how much I’d have now!

| Dr. James Fox

Dr James Fox explores whether AstraZeneca shares are right for his portfolio after two years of strong share-price growth.

Read more »

Affectionate Asian senior mother and daughter using smartphone together at home, smiling joyfully
Investing Articles

Best British shares to buy in November

| The Motley Fool Staff

We asked our writers to share their ‘best of British’ stocks to buy this month, including insurers and housebuilders.

Read more »

Young female analyst working at her desk in the office
Investing Articles

What on earth is going on with the AstraZeneca share price?

| Kevin Godbold

Is recent weakness in the AstraZeneca share price a buying opportunity for me after 10 years of impressive performance?

Read more »

Female Doctor In White Coat Having Meeting With Woman Patient In Office
Investing Articles

6 super investors hold this FTSE 100 stock. Should I buy it too?

| Mark Tovey

Some world-renowned investors have selected this FTSE 100 stock for their mega-portfolios. But have their investments been lucrative and is…

Read more »

Smiling young man sitting in cafe and checking messages, with his laptop in front of him.
Investing Articles

Down 10%, the most valuable stock on the FTSE 100 is starting to look cheap!

| Dr. James Fox

Dr James Fox investigates whether the FTSE 100's most valuable stock, AstraZeneca, looks like a good buy after its 10%…

Read more »

Mindful young woman breathing out with closed eyes, calming down in stressful situation, working on computer in modern kitchen.
Investing Articles

2 FTSE 100 shares to buy in the UK stock market crash

| Charlie Carman

Following the mini budget, FTSE 100 shares took a beating as the index sank below 7,000. Our writer picks two…

Read more »